Early intervention with epoetin alfa treats anaemia and improves quality of life in ovarian cancer patients undergoing chemotherapy
β Scribed by P.M. Wilkinson; H. Andersson; M. Antonopoulos; M. Lahousen
- Book ID
- 117658833
- Publisher
- Elsevier Science
- Year
- 2001
- Tongue
- English
- Weight
- 168 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Anemia, a commonly occurring morbidity in patients with cancer, often leads to diminished quality of life (QOL). Numerous clinical trials have shown that epoetin alfa treatment improves hematologic and QOL variables in cancer patients. The clinical trial analysis reported here was performed to asses
## Background: Hemoglobin increases have been associated with quality of life (qol) improvements in anemic cancer patients treated with epoetin alfa, but intervention generally has been reserved for symptomatic anemia or hemoglobin < 10 g/dl. relationships among hemoglobin, functional status, and p
## Abstract DOI 10.1002/cncr.11430